Comment on

• Reconsidering the role for digoxin in the management of acute heart failure syndromes.

  Gheorghiade M, Braunwald E. Gheorghiade M, et al. JAMA. 2009 Nov 18;302(19):2146-7. doi: 10.1001/jama.2009.1657. JAMA. 2009. PMID: 19920240 No abstract available.
• A proposed model for initial assessment and management of acute heart failure syndromes.

  Gheorghiade M, Braunwald E. Gheorghiade M, et al. JAMA. 2011 Apr 27;305(16):1702-3. doi: 10.1001/jama.2011.515. JAMA. 2011. PMID: 21521852 No abstract available.
• Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

  Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Preiss D, et al. JAMA. 2011 Jun 22;305(24):2556-64. doi: 10.1001/jama.2011.860. JAMA. 2011. PMID: 21693744
• Hospitalizations for heart failure in the United States--a sign of hope.

  Gheorghiade M, Braunwald E. Gheorghiade M, et al. JAMA. 2011 Oct 19;306(15):1705-6. doi: 10.1001/jama.2011.1510. JAMA. 2011. PMID: 22009103 No abstract available.